Ho Chi Minh City, March 18 -- Ho Chi Minh City will implement a market stabilisation programme covering around 350 essential medicines to ensure adequate supply and affordable prices for residents in 2026-2027.

Under a plan issued on March 17, the programme encompasses 20 groups of essential drugs commonly used in treating prevalent and chronic conditions. These include pain relievers, anti-inflammatory and anti-allergy drugs, cardiovascular and diabetes medicines, antibiotics, digestive and respiratory treatments, musculoskeletal drugs, as well as vitamins, minerals and traditional remedies. The list is developed based on actual demand and regulations of the Ministry of Health.

Participants include pharmaceutical manufacturers, distrib...